A scaffold functionalized with SS-31 and REDV peptides on Prussian blue nanoparticles protected endothelial cells, reduced inflammation, and accelerated endothelialization in diabetic rabbit vascular models.
Triple protectionSS-31 protects mitochondria, REDV attracts endothelial cells, PBNPs scavenge ROS — all in one scaffold
What the researchers found
The SS-31/REDV/PBNP-functionalized scaffold reduced EC apoptosis, promoted EC proliferation and migration under hyperglycemia, suppressed macrophage inflammatory cytokines, and accelerated endothelialization in diabetic rabbit vascular models.
Why it matters
Diabetic patients need heart valve replacements but heal poorly. A scaffold that addresses the diabetic healing environment could enable tissue-engineered heart valves for this large patient population.
How the study worked
Peptide coacervate-PBNP supraparticle functionalization of decellularized scaffolds, in vitro EC/macrophage studies under hyperglycemic conditions, and in vivo implantation in diabetic rabbit vascular models.
What this study cannot tell us
Rabbit vascular model; cardiac valve-specific conditions may differ. Short-term in vivo outcomes; long-term durability unknown. Manufacturing complexity.
How to read the evidence
Preclinical study with in vitro and diabetic animal model validation. Innovative multi-peptide approach but early-stage for clinical translation.
When this study was published
Published in 2025.
The bigger picture
This demonstrates how combining multiple therapeutic peptides in a single biomaterial platform can address the complex pathological environment of diabetic tissue healing.
Questions still open
- Would this scaffold perform in a full cardiac valve replacement model?
- Can the manufacturing process be scaled for clinical production?
- How long does the peptide-mediated protection last in vivo?
Common questions
Why do diabetic patients need special heart valve scaffolds?
How do the peptides help?
Read the original research
Peptide coacervate-Prussian blue hybrid supraparticle-tailored scaffolds for revitalizing diabetic heart valve regeneration via multiplex oxidative stress regulation.
Biomaterials, 327, 123798
Citation
Fan, Yang; Xingzhuang, Du; Zhiyu, Zhao; Gaoyang, Guo; Yunbing, Wang. (2026). Peptide coacervate-Prussian blue hybrid supraparticle-tailored scaffolds for revitalizing diabetic heart valve regeneration via multiplex oxidative stress regulation.. Biomaterials, 327, 123798. https://doi.org/10.1016/j.biomaterials.2025.123798